Since both NE and LCN2 have been shown to mediate neuroinflammation and BBB damage in stroke (64–68), reduced levels of NE and LCN2 in COX-2 deficient animals could be a potential mechanism underlying the vasculoprotective effects of COX-2 blockade in stroke. The gene discussed is PTGS2; the disease is stroke disorder.